Articles Tagged With:
-
Analysis Shows U.S. Drug Spending Far Exceeds All Other Nations
A recent study concluded there's no connection between research/development costs and prices, suggesting U.S. prescription drugs are priced primarily on the basis of what the market will bear.
-
Surgeon General Launches Opioid Education Campaign
Nation’s top doc outlines strategy to stem the tide of a troubling epidemic.
-
FDA Steps Back from Antibacterial Soap Products
Agency says certain antiseptic washes containing specific chemicals may do more harm than good.
-
Lawsuits Accuse Pharma Companies of Deceiving Docs Over Opioid Risks
Pharmaceutical companies, including OxyContin manufacturer, are being taken to task over what states are calling deceptive marketing of dangerous opioids.
-
Researchers: Zika Treatment May Lie in Existing Drugs
A team of researchers discovered compounds that could help combat Zika -- but don't look for them on the market anytime soon.
-
Hospital CMS CoPs Made Easy
Does your hospital have what it takes to comply with CMS Hospital CoPs? -
FDA: Don’t Mix Benzos, Opioids, and Cough Syrup
Federal agency issues boxed warning in regard to serious risks of mixing potent drugs.
-
Hospital Consult - September 2016
-
Seniors with Higher Continuity of Care Less Likely to Visit ED
In an analysis of those with Medicare, more consistent outpatient care was associated with decreased chances of an ED visit.
-
U.S. Preventive Services Task Force Recommends Against Genital Herpes Screening
The CDC estimates that about one in six U.S. residents ages 14-49 has genital herpes.1 In new draft guidance, the U.S. Preventive Services Task Force (USPSTF) recommends against using current blood tests to screen for genital herpes in people with no signs or symptoms of infection, including adolescents and adults, as well as pregnant women.2